References
- Derossi D. Trojan peptides: the penetratin system for intracellular delivery. Trends Cell Biol 1998;8:84–7
- Lindgren M, Langel U. Classes and prediction of cell-penetrating peptides. Methods Mol Biol 2011;683:3–19
- Zorko MÜL. Cell-penetrating peptides: mechanism and kinetics of cargo delivery. Adv Drug Deliv Rev 2005;57:529–45
- Vivès E. Present and future of cell-penetrating peptide mediated delivery systems: “is the Trojan horse too wild to go only to Troy?”. J Control Release 2005;109:77–85
- Xiang B, Dong DW, Shi NQ, et al. PSA-responsive and PSMA-mediated multifunctional liposomes for targeted therapy of prostate cancer. Biomaterials 2013;34:6976–91
- Zhang Q, Tang J, Fu L, et al. A pH-responsive α-helical cell penetrating peptide-mediated liposomal delivery system. Biomaterials 2013;34:7980–93
- Yang Y, Yang YF, Xie XY, et al. Preparation and characterization of photo-responsive cell-penetrating peptide-mediated nanostructured lipid carrier. J Drug Target 2014;22:891–900
- Escoffre JM, Mannaris C, Geers B, et al. Doxorubicin liposome-loaded microbubbles for contrast imaging and ultrasound-triggered drug delivery. IEEE Trans Ultrason Ferroelectr Freq Control 2013;60:78–87
- Tsu-Yin W, Wilson KE, Machtaler S, Willmann JK. Ultrasound and microbubble guided drug delivery: mechanistic understanding and clinical application. Curr Pharm Biotechnol 2013;14:743–52
- de Saint Victor M, Crake C, Coussios CC, Stride E. Properties, characteristics and applications of microbubbles for sonothrombolysis. Expert Opin Drug Deliv 2014;11:187–209
- Carvalho C, Santos RX, Cardoso S, et al. Doxorubicin: the good, the bad and the ugly effect. Curr Med Chem 2009;16:3267–85
- Aroui S, Brahim S, De Waard M, et al. Efficient induction of apoptosis by doxorubicin coupled to cell-penetrating peptides compared to unconjugated doxorubicin in the human breast cancer cell line MDA-MB 231. Cancer Lett 2009;285:28–38
- Cai S, Alhowyan AA, Yang Q, et al. Cellular uptake and internalization of hyaluronan-based doxorubicin and cisplatin conjugates. J Drug Target 2014;22:648–57
- Shi NQ, Gao W, Xiang B, Qi XR. Enhancing cellular uptake of activable cell-penetrating peptide-doxorubicin conjugate by enzymatic cleavage. Int J Nanomedinine 2012;7:1613–21
- Yang YF, Yang Y, Xie XY, et al. PEGylated liposomes with NGR ligand and heat-activable cell penetrating peptide-doxorubicin conjugate for tumor-specific therapy. Biomaterials 2014;35:4368–81
- Torchilin VP. Targeted pharmaceutical nanocarriers for cancer therapy and imaging. AAPS J 2007;9:E128–47
- Garde SV, Forte AJ, Ge M, et al. Binding and internalization of NGR-peptide-targeted liposomal doxorubicin (TVT-DOX) in CD13-expressing cells and its antitumor effects. AntiCancer Drugs 2007;18:1189–200
- Yang Y, Yang Y, Xie X, et al. Dual-modified liposomes with a two-photon-sensitive cell penetrating peptide and NGR ligand for siRNA targeting delivery. Biomaterials 2015;48:84–96
- Yang Y, Xie X, Yang Y, et al. Photo-responsive and NGR-mediated multifunctional nanostructured lipid carrier for tumor-specific therapy. J Pharm Sci 2015;104:1328–39
- Fischer PM, Zhelev NZ, Wang S, et al. Structure-activity relationship of truncated and substituted analogues of the intracellular delivery vector Penetratin. J Pept Res 2000;55:163–72
- Gao W, Xiang B, Meng TT, et al. Chemotherapeutic drug delivery to cancer cells using a combination of folate targeting and tumor microenvironment-sensitive polypeptides. Biomaterials 2013;34:4137–49
- Zhou ZY, Zhang P, Ren JL, et al. Synergistic effects of ultrasound-targeted microbubble destruction and TAT peptide on gene transfection: an experimental study in vitro and in vivo. J Control Release 2013;170:437–44
- Zhu F, Jiang Y, Luo F, Li P. Effectiveness of localized ultrasound-targeted microbubble destruction with doxorubicin liposomes in H22 mouse hepatocellular carcinoma model. J Drug Target 2015;23:323–34
- Zhang JA, Anyarambhatla G, Ma L, et al. Development and characterization of a novel Cremophorw EL free liposome-based paclitaxel (LEP-ETU) formulation. Eur J Pharm Biopharm 2005;59:177–87
- Du L, Jin Y, Zhou W, Zhao J. Ultrasound-triggered drug release and enhanced anticancer effect of doxorubicin-loaded poly(D,L-lactide-co-glycolide)-methoxy-poly(ethylene glycol) nanodroplets. Ultrasound Med Biol 2011;37:1252–8
- Negussie AH, Miller JL, Reddy G, et al. Synthesis and in vitro evaluation of cyclic NGR peptide targeted thermally sensitive liposome. J Control Release 2010;143:265–73
- Zhao ZX, Gao SY, Wang JC, et al. Self-assembly nanomicelles based on cationic mPEG-PLA-b-Polyarginine (R15) triblock copolymer for siRNA delivery. Biomaterials 2012;33:6793–807
- Stride E. Physical principles of microbubbles for ultrasound imaging and therapy. Front Neurol Neurosci 2015;36:11–22
- Mahalingam S, Raimi-Abraham BT, Craig DQ, Edirisinghe M. Formation of protein and protein-gold nanoparticle stabilized microbubbles by pressurized gyration. Langmuir 2015;31:659–66
- Parhizkar M, Stride E, Edirisinghe M. Preparation of monodisperse microbubbles using an integrated embedded capillary T-junction with electrohydrodynamic focusing. Lab Chip 2014;14:2437–46
- Fonseca SB, Pereira MP, Kelley SO. Recent advances in the use of cellpenetrating peptides for medical and biological applications. Adv Drug Deliv Rev 2009;61:953–64